Kevin D. Bunker, Chief Officer of Zentalis Pharmaceuticals ZNTL, has filed 0 purchases and 5 sales on the open market. The latest trade was on 23/12/20.

KB

KB

Kevin D. Bunker

Chief Scientific Officer

Company

Zentalis Pharmaceuticals ZNTL

First filing

23/02/14

Trades

9 trades

Buys / sales

0 / 5

12-month net buying

No record

Last trade

23/12/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Zentalis PharmaceuticalsZNTL	Open-market sale10b5-1 plan	23/10/04	23/10/06	6,068 sh2 trades	$19.51avg.	$118,373.08	−0.7%
Zentalis PharmaceuticalsZNTL	Open-market sale10b5-1 plan	23/05/26	23/05/31	80,000 sh	$30.02	$2,401,600	−84.2%
Zentalis PharmaceuticalsZNTL	Open-market sale	23/02/13–23/02/14	23/02/14	10,307 sh2 trades	$20.14avg.	$207,608.94	−1.2%